Title: Beck A, et al. Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov. 2017 May;16(5):315-337.
1461705-70-3 | (3-Fluorocyclopentyl)methanamine hydrochloride | AA00HXEI | MFCD26407693
1496050-19-1 | N-(2-Acetylphenyl)nonanamide | AA00HXNC | MFCD18319073
1523530-32-6 | (3S,4R)-3-Methoxyoxan-4-amine | AA00HXW4 | MFCD19215799
153239-91-9 | 5-Iodo-2-methyl-2,3-dihydropyridazin-3-one | AA00HY1G | MFCD22052654
1557138-33-6 | 6-(Trifluoromethyl)-1H-indole-2-boronic acid pinacol ester | AA00HY9N | MFCD28397296
1599486-33-5 | Mal-peg6-pfp | AA00HYHV | MFCD22683307
1624261-04-6 | Ethyl 1-(5-(methylamino)pyridin-2-yl)-1h-pyrazole-4-carboxylate | AA00HYOG | MFCD08703674
1643467-84-8 | 3-Chloro-4,5-difluorophenylboronic acid | AA00HZ0K | MFCD10697406
169284-08-6 | sodium 2-(1H-1,2,3-benzotriazol-1-yl)acetate | AA00HZ7I | MFCD08444238
1715119-46-2 | 3-Methyl-6-nitro-[1,2,4]triazolo[4,3-a]pyridine | AA00HZGY | MFCD22571091